Artios Pharma

Series-B
artios.com Biotech & Healthcare
Total Funding $115M
Latest Round $115M Series-B
Last Announced Nov 17, 2025
Investors Undisclosed
Decision Makers Profile Active

About Artios Pharma

Artios is a leading independent DDR Company with a strong pipeline of novel cancer therapies in development with first-in-class & best-in-class potential.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website artios.com
Domain Registered Date Undisclosed

Social & Network Presence

LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $115,000,000 · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Artios Pharma.

Funding History

1 Round
Series-B equity · Nov 17, 2025

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts